Application 079016
- Type
- ANDA
- Sponsor
- AUROBINDO PHARMA LTD
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ATOMOXETINE HYDROCHLORIDE | ATOMOXETINE HYDROCHLORIDE | CAPSULE;ORAL | 10MG | No | No |
| 002 | ATOMOXETINE HYDROCHLORIDE | ATOMOXETINE HYDROCHLORIDE | CAPSULE;ORAL | 18MG | No | No |
| 003 | ATOMOXETINE HYDROCHLORIDE | ATOMOXETINE HYDROCHLORIDE | CAPSULE;ORAL | 25MG | No | No |
| 004 | ATOMOXETINE HYDROCHLORIDE | ATOMOXETINE HYDROCHLORIDE | CAPSULE;ORAL | 40MG | No | No |
| 005 | ATOMOXETINE HYDROCHLORIDE | ATOMOXETINE HYDROCHLORIDE | CAPSULE;ORAL | 60MG | No | No |
| 006 | ATOMOXETINE HYDROCHLORIDE | ATOMOXETINE HYDROCHLORIDE | CAPSULE;ORAL | 80MG | No | No |
| 007 | ATOMOXETINE HYDROCHLORIDE | ATOMOXETINE HYDROCHLORIDE | CAPSULE;ORAL | 100MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A079016-001 | ATOMOXETINE HYDROCHLORIDE | ATOMOXETINE HYDROCHLORIDE | EQ 10MG BASE | CAPSULE / ORAL | AB | 2017-05-30 | |
| A079016-002 | ATOMOXETINE HYDROCHLORIDE | ATOMOXETINE HYDROCHLORIDE | EQ 18MG BASE | CAPSULE / ORAL | AB | 2017-05-30 | |
| A079016-003 | ATOMOXETINE HYDROCHLORIDE | ATOMOXETINE HYDROCHLORIDE | EQ 25MG BASE | CAPSULE / ORAL | AB | 2017-05-30 | |
| A079016-004 | ATOMOXETINE HYDROCHLORIDE | ATOMOXETINE HYDROCHLORIDE | EQ 40MG BASE | CAPSULE / ORAL | AB | 2017-05-30 | |
| A079016-005 | ATOMOXETINE HYDROCHLORIDE | ATOMOXETINE HYDROCHLORIDE | EQ 60MG BASE | CAPSULE / ORAL | AB | 2017-05-30 | |
| A079016-006 | ATOMOXETINE HYDROCHLORIDE | ATOMOXETINE HYDROCHLORIDE | EQ 80MG BASE | CAPSULE / ORAL | AB | 2017-05-30 | |
| A079016-007 | ATOMOXETINE HYDROCHLORIDE | ATOMOXETINE HYDROCHLORIDE | EQ 100MG BASE | CAPSULE / ORAL | AB | 2017-05-30 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A079016-001 | AB |
| A079016-002 | AB |
| A079016-003 | AB |
| A079016-004 | AB |
| A079016-005 | AB |
| A079016-006 | AB |
| A079016-007 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A079016-001 | ATOMOXETINE HYDROCHLORIDE | EQ 10MG BASE | CAPSULE / ORAL | AB | 2017-05-30 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A079016-002 | ATOMOXETINE HYDROCHLORIDE | EQ 18MG BASE | CAPSULE / ORAL | AB | 2017-05-30 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A079016-003 | ATOMOXETINE HYDROCHLORIDE | EQ 25MG BASE | CAPSULE / ORAL | AB | 2017-05-30 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A079016-004 | ATOMOXETINE HYDROCHLORIDE | EQ 40MG BASE | CAPSULE / ORAL | AB | 2017-05-30 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A079016-005 | ATOMOXETINE HYDROCHLORIDE | EQ 60MG BASE | CAPSULE / ORAL | AB | 2017-05-30 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A079016-006 | ATOMOXETINE HYDROCHLORIDE | EQ 80MG BASE | CAPSULE / ORAL | AB | 2017-05-30 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A079016-007 | ATOMOXETINE HYDROCHLORIDE | EQ 100MG BASE | CAPSULE / ORAL | AB | 2017-05-30 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A079016-001 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A079016-002 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A079016-003 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A079016-004 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A079016-005 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A079016-006 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A079016-007 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Atomoxetine | ATOMOXETINE | American Health Packaging | 10d36b32-0202-4c03-8a1a-cd5d53f231e7 | 2026-06-25 | Boxed warning, Warnings, Adverse reactions | 079016 ANDA079016 |
| Atomoxetine | ATOMOXETINE | Bryant Ranch Prepack | 35b42f0c-a183-478b-bced-652dc12b33ec | 2026-04-10 | Boxed warning, Warnings, Adverse reactions | 079016 ANDA079016 |
| Atomoxetine | ATOMOXETINE | Aurobindo Pharma Limited | 6f6bea0c-297b-43ff-8960-ecc11243e06e | 2025-12-12 | Boxed warning, Warnings, Adverse reactions | 079016 ANDA079016 65862-243 65862-242 65862-241 65862-244 |
| Atomoxetine | ATOMOXETINE | Rising Pharma Holdings, Inc. | 1cceab35-dc4a-40bc-a245-10b64820e217 | 2025-12-12 | Boxed warning, Warnings, Adverse reactions | 079016 ANDA079016 |
| Atomoxetine | ATOMOXETINE | A-S Medication Solutions | 50a20478-5f33-4ecd-b5d3-dbba855e5f6b | 2025-12-10 | Boxed warning, Warnings, Adverse reactions | 079016 ANDA079016 |
| Atomoxetine | ATOMOXETINE | Bryant Ranch Prepack | d4fe9217-1853-4f8b-9a93-77e511554ca1 | 2025-06-12 | Boxed warning, Warnings, Adverse reactions | 079016 ANDA079016 71335-2162 |
| Atomoxetine | ATOMOXETINE | A-S Medication Solutions | 24bb7238-7e12-48d1-a572-2c753e69f604 | 2023-06-06 | Boxed warning, Warnings, Adverse reactions | 079016 ANDA079016 |
| Atomoxetine | ATOMOXETINE | A-S Medication Solutions | ffdcc267-d6ae-41ee-97d9-2c7596545ce8 | 2023-04-24 | Boxed warning, Warnings, Adverse reactions | 079016 ANDA079016 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 65862-241 | Atomoxetine | Atomoxetine | Aurobindo Pharma Limited | ANDA | Current |
| 65862-241 | Atomoxetine | Atomoxetine | Aurobindo Pharma Limited | ANDA | Current |
| 65862-241 | Atomoxetine | Atomoxetine | Aurobindo Pharma Limited | ANDA | Current |
| 65862-241 | Atomoxetine | Atomoxetine | Aurobindo Pharma Limited | ANDA | Current |
| 65862-242 | Atomoxetine | Atomoxetine | Aurobindo Pharma Limited | ANDA | Current |
| 65862-242 | Atomoxetine | Atomoxetine | Aurobindo Pharma Limited | ANDA | Current |
| 65862-242 | Atomoxetine | Atomoxetine | Aurobindo Pharma Limited | ANDA | Current |
| 65862-242 | Atomoxetine | Atomoxetine | Aurobindo Pharma Limited | ANDA | Current |
| 65862-242 | Atomoxetine | Atomoxetine | Aurobindo Pharma Limited | ANDA | Current |
| 65862-243 | Atomoxetine | Atomoxetine | Aurobindo Pharma Limited | ANDA | Current |
| 65862-243 | Atomoxetine | Atomoxetine | Aurobindo Pharma Limited | ANDA | Current |
| 65862-243 | Atomoxetine | Atomoxetine | Aurobindo Pharma Limited | ANDA | Current |
| 65862-243 | Atomoxetine | Atomoxetine | Aurobindo Pharma Limited | ANDA | Current |
| 65862-243 | Atomoxetine | Atomoxetine | Aurobindo Pharma Limited | ANDA | Current |
| 65862-244 | Atomoxetine | Atomoxetine | Aurobindo Pharma Limited | ANDA | Current |
| 65862-244 | Atomoxetine | Atomoxetine | Aurobindo Pharma Limited | ANDA | Current |
| 65862-244 | Atomoxetine | Atomoxetine | Aurobindo Pharma Limited | ANDA | Current |
| 65862-244 | Atomoxetine | Atomoxetine | Aurobindo Pharma Limited | ANDA | Current |
| 65862-244 | Atomoxetine | Atomoxetine | Aurobindo Pharma Limited | ANDA | Current |
| 71335-2162 | Atomoxetine | Atomoxetine | Bryant Ranch Prepack | ANDA | Current |